Novel Therapeutics
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
102
NCT06644118
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Phase: Phase 1
Role: Collaborator
Start: Oct 23, 2024
Completion: Oct 31, 2028
NCT07167537
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
Start: Oct 31, 2025
Completion: Dec 31, 2028
Loading map...